About P&T JournalContacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
Vice President, Group Publisher
Production: Mary Ellen Curry,
Director of Production Services
Circulation: Jackie Ott, Circulation Manager
- 2014 Rate Card & Production Specs
- 2013 Rate Card & Production Specs
- Advertising Due Dates
- BPA Statement
Statement of Purpose
Guidelines for Authors
Part 3: Challenges Facing Health Care Plans in Implementing Coverage Policies for Pharmacogenomic and Genetic Testing
The final part of this series covers the usefulness of genetic testing, trends in insurance underwriting, and the anticipated pipeline for new biologics.
F. Randy Vogenberg, PhD, RPh; Carol Isaacson Barash, PhD; and Michael Pursel, RPh, MBA
Efficacy and Safety of a Lower-Dose Valganciclovir (Valcyte) Regimen for Cytomegalovirus Prophylaxis In Kidney and Pancreas Transplant Recipients
Using a lower dose of valganciclovir, at 450 mg daily for six months instead of the recommended 900-mg daily dose, can be efficacious for patients and less expensive for hospitals. The result: reduced drug costs and fewer cases of leukopenia.
Vrinda Bhat, PharmD, Megan McIntyre, PharmD, and Tracey Meyers, PharmD
A Literature Review from a Global Health Systems Perspective
Although the burden of psoriatic arthritis has been described extensively in the literature, the burden of illness associated with PsA has not been as well qualified. The authors discuss the substantial economic and quality-of-life costs to patients and society.
Seina Lee, PharmD, MS; Alan Mendelsohn, MD; and Evelyn Sarnes, PharmD, MPH
Topics include onabotulinumtoxinA (Botox) for migraine; dabigatran (Pradaxa) for reducing stroke and embolism risk; and lurasidone (Latuda) for schizophrenia.
Marvin M. Goldenberg, PhD, RPh, MS
Selected sessions focused on incobotulinumtoxinA (Xeomin) for focal dystonias.
Isabel, a Web-based checklist system, could become a valuable aid to clinicians in reducing the number of incorrect diagnoses.
David B. Nash, MD, MBA
Despite earlier precautions from drug companies and the FDA, health care professionals are still prescribing fentanyl patches inappropriately.
Matthew Grissinger, RPh, FASCP
Hospitals Say Curtailed Payments Shouldn’t Apply to Them
The Centers for Medicare and Medicaid Services needs to clarify its new reimbursement rules for "intentional overfill" of injectable drugs.
FDA approvals, drug indications, and updates
An Aid to Walking in Patients with Multiple Sclerosis
Raymond Lamore III, PharmD Candidate, Elsen Jacob, PharmD Candidate, Susan C. Jacob, PharmD Candidate, and Olga Hilas, PharmD, MPH, BCPS, CGP